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Abstract: In the present study, a newly innovative drug delivery system of biphasic Metronidazole (MTZ) tablet 
has been studied. An attempt was made to improve the patient’s adherence and the potential clinical outcomes 
by reducing the dosing frequency by formulating bilayer tablets containing Metrodinazole. Each bilayer tablet 
is composed of a sustained release (SR) layer and an immediate release (IR) layer for rapid drug release. Five 
different formulations of bilayer tablets were formulated using HPMC as hydrophilic polymer to retarded the 
drug release and the effect of Starch and MCC on the release profile were evaluated. Wet granulation method 
was used to prepare granules of the immediate and sustained release layers. The tablets were evaluated for 
their physical parameters and all valuesobtained found to be within the acceptable limits. The dissolution test 
has been carried out using the USP type II rotating paddle. Collected samples were analyzed using the high 
performance liquid chromatography. The mechanisms of Metrodinazole release from the sustained release layer 
were fitted into zero-order, first order, Higuchi, Hixon- Crowell model and Korsmeyer-Peppas release model. 
The results of the dissolution profiles showed that the drug release from  the sustained release layer varied 
depending on the amount of HPMC  and the presence of Starch or MCC. The kinetics of the release of MTZ 
from the different formulations showed good fitting with Higuchi model with correlation coefficients (R2) of  
0.9965 - 0.9985. From values obtained for the diffusional exponent, n, Korsmeyer-Peppas  equation observed 
that for all the formulations n value ranged from 0.4662  to 0.5370, and this demonstrates that the release 
mechanism followed non-Fickian type of release ( anomalous transport). 
Keywords: Biphasic tablets, HPMC immediate release, infectious diseases, Metronidazole, sustained release. 
 
I. Introduction 
Oral drug delivery systems are the most utilized route of administration today; this is due to  of the 
flexibility in modifying the release pattern of the drug. Tablets among all other orally administered dosage forms 
are highly preferred because of their stability, ease of manufacturing and ease of patients’ administration. The 
biphasic delivery system is a new innovative drug delivery system utilized to provide immediate and sustained 
release doses within the same tablet, thus compliance problems associated with multiple dosing regimens can be 
overcome [1]. 
 Diarrheal infections for example, were ranked at the top ten causes of death by the WHO[2]. 
Metronidazole (MTZ) is an antimicrobial, antiprotozoal medication that is used for multiple infectious diseases 
caused by different organisms, including protozoans, Helicobacter pylori, anaerobic bacteria, primarily Gram 
negative and Gram positive anaerobes.  MTZ has a concentration dependent killing with rapid bactericidal 
property and good tissue penetration[3]. It is also well absorbed orally, with relatively short elimination   half-
life   ranging   from   6–8 hours; therefore the use of a sustained release system will be highly beneficial. The 
general dosing regimen of MTZ is from 2 to 4 times a-day for 7 to 14 days. It is available as 250, 500 mg 
immediate release tablets (IR)  and 750 mg extended release tablets (ER) as well. A biphasic tablet of 1000 mg 
MTZ is a new novel that is developed to replace multi dosing regimen with once daily. This will improve 
patients’ compliance, thus minimizing bacterial resistance as well as improving the clinical efficacy. Moreover, 
this biphasic tablet is designed to target specific conditions that use 1000 mg per day, such as: Pelvic 
inflammatory disease, bacterial vaginosis, trichomoniasis, Helicobacter pylori infection and others. Biphasic 
MTZ tablets are composed of two different layers; the first immediate release layer and the second  extended 
release layer, in a quick\slow release pattern.  This system provides an initial burst of drug (Loading dose) with 
rapid onset of action. A high Cmax will be achieved rapidly, which will support the mechanism of action of 
MTZ, followed by sustained release pattern to maintain plasma drug levels for extended period of time. 
HPMC polymer has been used in many studies successfully to sustain the release of different 
formulations [4][5][6] Moreover, sustained release matrix tablets of MTZ were successfully prepared using 
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HPMC polymer to retard the release of the drug[7].  HPMC retardation of drug release occurs by swelling of the 
matrices upon the exposure to the gastric fluids. By time the matrix willerode and \ or dissolve and release the 
drug slowly [8][9]. Starchand Microcrystalline cellulose (Avicel® PH 101)  were used to increase the drug 
release[10]. Magnesium stearate was used a lubricant andPolyvinylpyrrolidone (PVP) was used as a binder. 
The aim of this study was to prepare biphasic MTZ tablets using HPMC polymer. This dosage form  is 
composed of 250 mg MTZ in the IR layer and 750 mg in the ER layer which will provide an initial loading dose 
with rapid onset of action followed by sustained release pattern to maintain a plasma drug levels over a long 
period of time. 
 
II. Materials And Methods 
1. Materials: 
MTZ was obtained as a gift from Jerusalem Pharmaceutical Company. HPMC (10000SH) was gifted from 
Pharmacare Phamaceutical Company. Microcrystalline cellulose (Avicel®PH 101), corn starch 1500, 
magnesium stearate and polyvinylpyrrolidone (PVP) were gifted from SamihDarwazeh Institute of Industrial 
Pharmacy. All reagents used in these experiments were of analytical grades. 
 
2. Preparation of immediate and sustained  release layers  
The wet granulation method was used to prepare granules of the immediate and sustained release. The 
composition  of the different formulations is shown in TABLEI. The excipients and the active ingredient 
wereblended and granulated with 70% ethanol using granulate stand mixer apparatus. The wet mass was passed 
through sieve #18 and the granules were dried at temperature of 40
o
 C for 2 hours. The dried granules were then 
blended with magnesium stearate. 
 
3. Compression of bilayer tablets 
The immediate release granules were placed in the die cavity and precompressed . Then the sustained release 
granules were placed in the die cavity and allowed for punching with optimum hardness to form bilayer tablets. 
Compression was done using 19x8 mm diameter caplet die in a single rotary punch MINIPRESS MII machine.  
 
4. Granules evaluation  
4.1 Angle of repose 
Angle of repose test was carried out to characterize the flow properties for the IR and the SR granules. The 
funnel method was used to determined the angle of repose of granules. A measured quantity of each type of 
granules was placed in a funnel. The funnel was fixed in place, 5 cm above the bench surface. The granules 
were then allowed to flow through the funnel orifice. The height  (h) and the radius (r) of the heap formed were 
measured[11]. The test was repeated three times and the angle of repose (Q) was calculated through the 
following equation: 
Q = tan-1 (h/r)                                                                                                 equation.1 
 
4.2 Bulk and Tap Densities 
Bulk density (BD) and tap density (TB) were determined using method I outlined in the USP[12].A measured 
quantity of each type of granules was added to a graduated cylinder of tapped density apparatus (COPLEY). 
After the initial volume was observed, the cylinder was allowed to fall under its own weight onto a hard surface. 
The tapping was continued until no further change in volume was noted. BD and TB were calculated using the 
following formulas. 
BD = Weight of the powder/Volume of the powder (Vbulk)                                   equation.2 
TD = Weight of the powder/Minimum volume of the powder (Vtap).                    equation.3 
 
4.3 Percentage Compressibility (Carr’s index) and Hausner’s Ratio 
The percentage compressibility (CI) was calculated from the difference between the TD and BD divided by the 
TD and the ratio expressed as a percentage. The Hausner’s ratio (HR) is the ratio between the 
TD and BD[11]. 
CI = [(TD-BD)/TD] ×100                                                                                        equation.4 
HR = TD/BD                                                                                                           equation.5 
   
5. Tablets evaluation 
The prepared tablets were subjected to various evaluation tests such as weight variation, hardness, friability, and 
dissolution test. 
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5.1 Weight Variation Test 
Weight variation test was done by weighing 20 tablets individually and collectively, calculating the average 
weight from the collective weight and comparing the individual tablet weight to the average weight [13]. 
5.2 Hardness 
Hardness was determined using Hardness Tester (Pharmatest PTB 311E ). Ten tablets were randomly selected; 
the mean and standard deviation were calculated.  
5.3 Friability 
Ten pre-weighed tablets were taken randomly and placed into the Three Drum Automated Friability Testing 
(Pharmatest PTF 3DR).The machineset to rotate 100 times. Tablets were reweighed after the removal of fines 
and the percentage of weight loss was calculated. Friability results below 1% was considered acceptable based 
on US [14].  
F= (W initial – W final)/ W initial *100%.equation.6 
 
5.4 In Vitro Release study 
Six tablets of each formulation of MTZ  were taken and tested for dissolution. The USP type II rotating 
paddle (SOTAX dissolution tester CLI119)  was used to study the drug release from the bilayer tablets. The 
dissolution medium consisted of 750 ml 0.1 M HCL for the first two hours, then 250 ml buffer was added to 
achieve 1000 ml phosphate buffer pH 6.8 for the next 22 hours according to method A in USP[15]. The 
dissolution test was performed at 37 ± 0.5
o
C, with a rotation speed of 50 rpm. A sample of 5 ml from the 
dissolution medium was withdrawn using SOTAX  autosamplar at the interval of 30 min up to 120 min. After 
that samples were withdrawn  at 3
rd
  hour followed by 2 hr intervals up to 24 hrs. The sample volume was 
replaced by an equal volume of dissolution medium after each withdrawal. Collected samples were analyzed 
using the high performance liquid chromatography device (HPLC). MTZ release were determined using a 
validated HPLC method. The HPLC analysis was performed using shimadzue HPLC consisting of a pump, 
autosampler, column oven, UV detector and LC solution. C8 column was used at a UV detection wavelength of 
278 nm. Methanol/water  (20:80, v/v), as the mobile phase. Column temperature was maintained at 30°C. Flow 
rate and injection volume were 1.0 ml/minand 10 um, respectively.  
 
6. Kinetic Data Analysis 
6.1 Mechanism of Drug Release 
To explain  the mechanisms of MTZ release  from sustained release layer of different formulations , the 
obtained data  of drug release were fitted into zero-order, first order, Higuchi, Hixon- Crowell model and 
Korsmeyer-Peppas release model [16-21].  
6.2 Zero – order question 
To analyze release kinetics, the in vitro release data were plotted as cumulative amount of drug released versus 
time. Zero order describes the kinetics where the  drug release rate from the tablet is independent from the 
concentration of dissolved drug. The release rate data are fitted into the following equation. 
Qt=Q0+K0 t                                                           equation.7 
Where,  
Qt  is the amount of drug dissolved in time t, Q0 is the initial amount of drug in the solution (most times, Q0 = 0) 
and  
K0 is the zero order release constant expressed in units of concentration/time. 
6.3 First order equation 
To study the First order release kinetics the release rate  data are fitted to the following equation. The data are 
expressed as  log cumulative percentage of drug remaining versus time. According to First equation order the 
drug release rate depends on its concentration.  
 
logC=logC0- Kt/2.303                                        equation.8 
where,  
C = The amount of drug un-dissolved at t time, 
C0 = Drug concentration at t = 0, 
Kt = First order  release rate constant.  
 
6.4 Higuchi equation 
Higuchi equations assumes  that the drug released from the tablet by diffusion mechanism. The data are 
expressed as   cumulative percentage of drug release versus square root of time  which  fitted to the following 
equation:  
Q=k√tequation.9 
Where, 
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Qt  is the amount of drug dissolved in time t,  
K0 is Higuchi release constant. 
 
6.5  Hixon- Crowell model 
Hixson-Crowell cube root model  represents  the drug release pattern  depending on the change in surface area 
and diameter of the particles / tablets. This model is applied for the systems which erode over time. The 
following equation where used  
Q0
^(1/3)
 -Qt
^(1/3)
 =k t                                                           equation.10 
Where, 
Qt  is the amount of drug release in time t,  
Q0 is the initial amount of drug in the tablet  
K0 is the rate constant for Higuchi, Hixon- Crowell cube root model 
The data are expressed as Cube root of cumulative percentage of drug remaining versus time. 
 
6.6 Korsmeyer-Peppas release model 
To elucidate the mechanism of drug release the data were further analyzed using equation proposed 
by Korsmeyer and Peppas. The following equation where used  
Q/Q0 =k t
n
equation.11 
where  
Q/Q0 = the fraction of drug release at time t 
 k is the kinetic constant, and n is the diffusion or release  exponent which depends on the release mechanism. 
When n = 0.45 indicate Fickian diffusion release, when 0.45 < n <0.89 indicate anomalous release kinetics 
(coupled diffusion/relaxation), and when  0.89 < n < 1 indicate a zero-order release. 
 
III. Result And Discussion 
The granules for both Layers of the different formulations were evaluated for Bulk Density, Tab Density, 
Compressibility index, Hausner ratio and Angle of Repose (Table II). The values of precompression parameters 
showed that the granules for all formulations have sufficient compressibility and flow  properties. 
 
1. Physical  Evaluation of tablets  
The result of physical evaluation of bi-layer tablets like weight variation, hardness and friability were 
represented in Table III. Weight variation of the prepared tablets  was found within the limits of pharmacopoeia 
[13].One of the main reasons for weight uniformity test is to guarantee  appropriate flowability of powders. 
Friability test results range between [ 0.2-0.71 %], which met the acceptable limits of less than 1% according to 
USP [14], which indicate good mechanical resistance. Hardness ranged between [10-12] newton, which reflects 
good mechanical strength.  
 
2. In vitro dissolution 
The dissolution profile of different formulations of sustained release MTZ  layer and from biphasic 
MTZ tablets are shown in Fig.1 and Fig.2 respectively. The dissolution  data   were analyzed and plotted as the 
cumulative percent drug release vs time. Formulations F1, F3, F5, F7 and F9 showed release for 24 hr up to 
84.17%, 87.5%, 91.33%, 96.13% and 99.51% respectively(Fig.1). The drug release from  the sustained release 
layer varied depending on the amount of HPMC  and the presence of Starch or MCC. Formulation F1 showed 
release less than F3 and F5 due to combination of the hydrophilic polymer(HPMC) in the formulations F3 and 
F5 with Starch or MCC respectively. From  Fig.1 it was seen that the drug release was higher for Starch and 
highest for MCC than the formulations without filler. This release behavior can be attributed to the solubility of 
MCC in water which forms pores in the gel layer  resulting in  more penetration of dissolution medium to the 
core of the tablets. On the other hand the use of starch in the tablets retarded the drug release and this 
behaviorcausedby two reasons. The first is due to the interaction between Starch and HPMC.This interaction can 
affect the properties of the gel layer  around the tablets causing to slower penetration of dissolution medium to 
the  core of the matrix. The second is due to the property of starch to hydrate and form a gel layer  barrier due to 
intramolecular hydrogen bonds in the highly  branched amylopectinwhich affect the gel layer and retard the 
drug release[22-23]. Formulations F3 and F5 showed less release than F7 and F9 due to less concentration of 
hydrophilic polymer(HPMC) in the formulations F7 and F9. Formulations F2, F4, F6, F8 and F10 showed 
release for 24 hr up to 84.51%, 88.11%, 91.2%, 94.1% and 99.5% respectively(Fig.2). For all formulations more 
than 40% of MTZ was released  within 2 hours of dissolution test. This burst release of MTZ can be due to the 
immediate release layer of the formulation. Further release of MTZ was from the sustained release layer for 24 
hours.  
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3. Kinetics and mechanism of drug release 
To explain and evaluate the pattern and mechanism of drug release kinetics the in vitro data obtained 
from MTZ dissolution of sustained release layer were fitted to kinetic models, Zero order, first order , Higuchi , 
Hixson-Crowell equations  and  Korsmeyer-Peppas. The suitability of the model has been  judged on the basis 
of best fit to the model using the correlation coefficient value (R2). The data obtained from analysis of drug 
release kinetics are  listed as shown in TABLE (IV). Figure (3) show  the results of data analysis according  to 
Zero order (Fig.3-a ), first order (Fig.3-b ), Higuchi (Fig.3-c ), Hixson-Crowell equations (Fig.3-d ) for 
formulation F1. 
From the results shown in TABLE (IV), it can be observed  that the release kinetics of MTZ from the 
different formulations showed good fitting with first order, zero order and Hixson-Crowell with R2 values 
0.8453 - 0.9891,  0.9162 - 0.9526 and 0.9728-0.9907 respectively. On the other hand the  model with the highest 
correlation coefficients (R2) were given by Higuchi with R2 values 0.9965 - 0.9985.  Although the results 
indicate that the drug is   released due to  erosion of the gel layer formed around the tablet and simultaneous 
diffusion of the drug from this layer. The drug released by diffusion appears to be  the main mechanism. These 
results can be confirmed by the apparent swelling behavior of the tablets. It was observed during the dissolution 
experiments a continuous  increase in the thickness of the gel layer formed around the tablets. In addition, the 
release profile of MTZ from all formulations displayed good fitting with Hixson-Crowell cube root model of 
drug release, implying that erosion might have resulted in the release of MTZ from the tablets . It can be 
concluded that the kinetics of this drug release from the tablets can be attributed to erosion and diffusion 
mechanism with the diffusion mechanisms maybe the predominant.   
To explain  the mechanism of MTZ  release, the dissolution data were also fitted to  exponential 
Korsmeyer–Peppas equation and value of release exponent (n) explains the release mechanism of the drug from 
the tablets. 
The calculated n values are shown in TABLE ( IV ). From values obtained for the diffusional exponent, 
n, it can be observed that for all the formulations n value ranged from 0.4662  to 0.5370, and this demonstrates 
that the release mechanism followed non-Fickian type of release ( anomalous transport). For all formulations the 
n values were less than 0.89  indicating a close to Highuchi  release mechanism. Such release pattern could be 
attributed to the physical structure of the polymer network and to the strong entanglements HPMC chains which 
resisted the gel layer erosion by the dissolution medium [24].   
It can also be observed from the results shown in TABLE (IV) that the presence of filler ( Starch 13% 
or MCC 16.6 % ) has no significant  influence on the kinetics of drug release. The  values of n for tablets 
without fillers (F1 ) and for tablets with fillers (F3 and F5) were  0.5370, 0.5031 and 0.4763 indicating an 
anomalous behavior corresponding to diffusion, erosion and swelling mechanisms. A linear trend of decreasing 
n values can be observed from tablets without filler to Starch and to MCC respectively. Tablets containing MCC 
exhibited a drug release closer to a diffusion-controlled process compared to Starch and to tablets without filler. 
Other research groups have reported similar results that the drug release mechanism was affected by the 
presence of filler. They found that the  matrices containing lactose exhibited a drug release closer to a diffusion-
controlled process compared to MCC and Starch 1500 [25]. 
 
IV. Conclusion 
The present study was carried out to design  oral bilayer tablet of Metrodinazole  containing   250 mg 
MTZ in the IR layer and 750 mg MTZ in the ER layer using HPMC 100000SH.  The granules  of different 
formulations have good flow properties and the prepared tablets have good physical characteristics. The Bilayer 
tablets showed an initial burst effect to provide the loading dose of the drug, followed by sustained release for 
24 h, indicating a promising potential of the Metrodinazole bilayer tablet as an alternative to the immediate 
release dosage form.The drug release from  the sustained release layer varied depending on the amount of 
HPMC  and the presence of Starch or MCC. The analysis of the release kinetic data for the different  
formulations  in this study shows that Higuchi’s model can best describe the kinetics of  MTZ conforming to  
the  diffusion  assisted mechanism. Furthermore analysis of release kinetics data using Korsmeyer–Peppas 
equation shows that the release mechanism followed non-Fickian type of release ( anomalous transport). It can 
beconcluded that the present study indicates that the bilayer tablets of MTZ provides a better option 
fordevelopment of a once daily formulation of the drug. 
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Table I: Composition of biphasic Metronidazole tablets 
 
 
Table II: Pre-compression evaluation tests on the prepared granules 
 
 
Table III: Post-compression evaluation tests on the prepared biphasic MTZ tablets 
 
 
 
 
 
 
 
 
 
 
 
Table IV: Kinetics data of Metrodinazole  release from  plots of formulation F-1 , F3, F5, F7, and F9 
 
 
 
 
 
 
 
Formulations Hardness N  ±SD 
(n 10) 
Friability (%) 
( n 6 ) 
Weight (mg) ±SD 
(n 10) 
Release in 24 
hours (%) 
F1 10 0.47 820 ± 0.07 84.16% 
F2 10.5 0.32 1140 ± 0.08 84.51% 
F3 12 0.55 960 ± 0.02 87.5% 
F4 10.8 0.65 1260 ± 0.07 91.3% 
F5 11.6 0.71 900 ± 0.09 88.1% 
F6 12 0.70 1280 ± 0.09 91.2% 
F7 10.7 0.20 950 ± 0.01 96.1% 
F8 12.2 0.25 1260 ± 0.02 94.1% 
F9 10.4 0.30 990 ± 0.06 99.51% 
F10 11.9 0.38 1300 ± 0.09 99.5% 
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Figure 1: Cumulative MZT released vs. time from different formulations  (mean ± SD, n = 6) 
 
 
Figure  2: Cumulative MZT released vs. time from different formulations  (mean ± SD, n = 6) 
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Figure 3: kinetic evaluation of formulation (F1): a) Zero Order plot, b) First Order plot, c) Higuchi plot, d) 
Hixson-Crowell plot. 
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